Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response

about

Recurrent Syncope, a Clue in Amyloid Cardiomyopathy.Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018.Storage diseases with hypertrophic cardiomyopathy phenotype Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass

P2860

Q52645922-1BB029DF-7F35-4EE6-BFE4-A0C495E89A1C Q55023498-D2A33788-8FAF-4A82-B063-9CDAAB124076 Q58565558-C4F54F19-2B44-440D-9D56-97224BCA7B86 Q58695482-043D40B9-7CF8-41F6-BB4D-596755B507D4

P2860

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response

Item

http://www.wikidata.org/entity/Q39272596

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Light-chain cardiac amyloidosi ...... diagnosis and cardiac response

@en

Light-chain cardiac amyloidosi ...... iagnosis and cardiac response.

@nl

type

Item

label

Light-chain cardiac amyloidosi ...... diagnosis and cardiac response

@en

Light-chain cardiac amyloidosi ...... iagnosis and cardiac response.

@nl

prefLabel

Light-chain cardiac amyloidosi ...... diagnosis and cardiac response

@en

Light-chain cardiac amyloidosi ...... iagnosis and cardiac response.

@nl

P1476

Light-chain cardiac amyloidosi ...... diagnosis and cardiac response

@en

P2093

Martha Grogan

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis

Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway.

Implantable cardioverter defibrillators in patients with cardiac amyloidosis.

First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction

Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis.

Cardiac amyloidosis: updates in diagnosis and management.

Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.

Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.

Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis.

P304

1065-1072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1136/HEARTJNL-2016-310704

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Angela Dispenzieri

Morie A Gertz

P5008

ScienceSource

P577

2017-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28456755

http://www.w3.org/2001/XMLSchema#string

P921

P932

5566095

http://www.w3.org/2001/XMLSchema#string

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response

about

P2860

P2860

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P50

P5008

P577

P698

P921

P932